ML20055C943
| ML20055C943 | |
| Person / Time | |
|---|---|
| Issue date: | 05/07/1990 |
| From: | Taylor J NRC OFFICE OF THE EXECUTIVE DIRECTOR FOR OPERATIONS (EDO) |
| To: | Hollings E SENATE |
| Shared Package | |
| ML20055C944 | List: |
| References | |
| FRN-55FR1439, RULE-PR-35 CCS, NUDOCS 9007020119 | |
| Download: ML20055C943 (2) | |
Text
.
.i i
i *'
' [p riog#'o UNITED STATES 8-
g E"
NUCL'iAR REGULATORY COMMISSION n
,E W ASHINGTON, O C. 20$5$
\\...../
May 7, 1990 The Honorable Ernest F. Hollings United States Senate Washington, DC 20510-4002
Dear Senator Hollings:
l Thank you for your letter of April 20, 1990, regarding comments by Piedmont p
Oncology Associates, P.A. and Dr. Mark C. Bruels of Greenville, South Carolina l
on proposed amendments to 10 CFR Part 35 The ruclear Regulatory Commission published a proposed rule on January 16,-1990, on " Medical Use of Byproduct Material" that would require medical use licensees to implement a basic quality assurance program and that would modify the -
reporting and recordkeeping requirements. The public comment period closed April 12, 1990.. To date, we have received 66 public coment letters, including '
the letters which were enclosed with your letter.
The issues raised by the public comments will be evaluated and used in s
determining the need for, and if needed, the form of a final rule.
In addition, we are condu'cting a pilot program to try out the proposed performance based regulatory requirements using a projected 65 volunteer medical use licensees from across the United States. Their experience, evaluations, and suggestions will also be evaluated as part of our activities to determine the need for a final rule, and if needed the specific form of the rule.-
- i I
I want to assure you that the comments of Piedmont Oncology Associates and Dr. Bruels will be carefully considered with the other public ccmments in our evaluation.
I trust that the above information is responsive to your request.
Sincerely,
}
/
K J mes M. T lor xecutive Director for Operations FULLTEXT ASCil SCAN k
klI9900507 d5 55FR1439 PDC
L L May 7, 1990
.The Honorable Ernest F. Follings
' United States Senate Pashington, DC 20510-4002
Dear Senator Hollings:
Thank you for your letter of April 20, 1990, regarding coments by Piedmont Oncology Associates, P. A. and Dr. Mark C.-Bruels of Greenville, South Carolina on proposed amendments to 10 CFR Part 35.
The Nuclear Regulatory Comission published a proposed rule on January 16, 1990, on " Medical Use of Byproduct Material" that would require medical use licensees to implement a basic quality assurance program and that would mcdify the reporting and recordkeeping requirements. The public coment period closed April 12,1990. To date, we have received 66 public coment letters, including-the letters which were enclosed with your letter.
The issues raised by the public comments will be evaluated and used in determining the need for, and if needed, the form of a final rule.
In addition, we are conducting a pilot program to try out the proposed performance based regulatory requirements using a projected 65 volunteer medical use licensees from across the United States. Their experience, evaluations, and suggestions will also be evaluated as part of our activities to determine the need for a final rule, and if needed the specific form of the rule.
I want to assure you that the coments of Piedmont Oncology Associates and Dr. Bruels will be carefully considered with the other public coments in cur evaluation.
I trust that the above information is responsive to your request.
Sincerely, Original Signed Bys James M. Taylor James M. Taylor Executive Director
-for Operations
- See Previous Concurrence 3
0FFICE:RDB:DRA RDB:DRA DD:DRA D:DRA DD D:RES P HAME: *JTelfor
- SBahadur "FCostanzi *BMorris (H
mes EBeckjord DATE:
5/01/9 5/01/90 5/01/90 5/01/90 5/
0
$'/3 /90 0FFICE:EDO.
OCA m,
NAME:.JTay1 l
DRathb W Q,0
<34/90 DATE 0FFICIAL RECORD COPY